Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Norris, K. Barriga, G. Klingensmith, M. Hoffman, G. Eisenbarth, H. Erlich, M. Rewers (2003)
Timing of initial cereal exposure in infancy and risk of islet autoimmunity.JAMA, 290 13
M. Knip, S. Virtanen, K. Seppä, J. Ilonen, E. Savilahti, O. Vaarala, A. Reunanen, K. Teramo, A. Hämäläinen, J. Paronen, H. Dosch, T. Hakulinen, H. Akerblom (2010)
Dietary intervention in infancy and later signs of beta-cell autoimmunity.The New England journal of medicine, 363 20
S. Virtanen, L. Räsänen, A. Aro, J. Lindström, H. Sippola, R. Lounamaa, L. Toivanen, J. Tuomilehto, H. Akerblom (1991)
Infant Feeding in Finnish Children <7 yr of Age With Newly Diagnosed IDDMDiabetes Care, 14
H. Holmberg, J. Wahlberg, O. Vaarala, J. Ludvigsson (2007)
Short duration of breast-feeding as a risk-factor for β-cell autoantibodies in 5-year-old children from the general populationBritish Journal of Nutrition, 97
A. Ziegler, Michael Hummel, M. Schenker, E. Bonifacio (1999)
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.Diabetes, 48 3
C. Patterson, G. Dahlquist, É. Gyürüs, A. Green, G. Soltész (2009)
Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration studyThe Lancet, 373
S. Virtanen, Michael Kenward, M. Erkkola, S. Kautiainen, C. Kronberg-Kippilä, Timo Hakulinen, S. Ahonen, L. Uusitalo, S. Niinistö, R. Veijola, Olli Simell, Olli Simell, J. Ilonen, J. Ilonen, Mikael Knip, Mikael Knip (2006)
Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetesDiabetologia, 49
O. Vaarala, Mikael Knip, J. Paronen, A. Hamalainen, Päivi Muona, Minna Väätäinen, J. Ilonen, O. Simell, H. Akerblom (1999)
Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.Diabetes, 48 7
M. Knip (2002)
Can we predict type 1 diabetes in the general population?Diabetes care, 25 3
P Kumala, K Savola, JS Petersen (1998)
Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes?a population-based study., 101
V. Harjutsalo, R. Sund, M. Knip, P. Groop (2013)
Incidence of type 1 diabetes in Finland.JAMA, 310 4
M. Knip (2004)
Natural Course of Preclinical Type 1 DiabetesHormone Research in Paediatrics, 57
T. Kimpimäki, T. Kimpimäki, A. Kupila, A. Hämäläinen, A. Hämäläinen, M. Kukko, M. Kukko, P. Kulmala, P. Kulmala, K. Savola, K. Savola, T. Simell, P. Keskinen, J. Ilonen, J. Ilonen, Olli Simell, Mikael Knip, Mikael Knip, Mikael Knip (2001)
The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.The Journal of clinical endocrinology and metabolism, 86 10
O. Vaarala, J. Ilonen, T. Ruohtula, J. Pesola, S. Virtanen, T. Härkönen, M. Koski, H. Kallioinen, O. Tossavainen, T. Poussa, A. Järvenpää, J. Komulainen, R. Lounamaa, H. Akerblom, M. Knip (2012)
Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study.Archives of pediatrics & adolescent medicine, 166 7
H. Akerblom, S. Virtanen, J. Ilonen, E. Savilahti, O. Vaarala, A. Reunanen, K. Teramo, A. Hämäläinen, J. Paronen, M. Riikjärv, A. Ormisson, J. Ludvigsson, H. Dosch, T. Hakulinen, M. Knip, National Groups (2005)
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot studyDiabetologia, 48
A. Ziegler, S. Schmid, Doris Huber, M. Hummel, E. Bonifacio (2003)
Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies.JAMA, 290 13
P. Kulmala, K. Savola, J. Petersen, P. Vähäsalo, J. Karjalainen, T. Löppönen, T. Dyrberg, H. Akerblom, M. Knip (1998)
Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.The Journal of clinical investigation, 101 2
A. Ziegler, M. Rewers, O. Simell, T. Simell, J. Lempainen, A. Steck, C. Winkler, J. Ilonen, R. Veijola, M. Knip, E. Bonifacio, G. Eisenbarth (2013)
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.JAMA, 309 23
M. Knip, S. Virtanen, H. Akerblom (2010)
Infant feeding and the risk of type 1 diabetes.The American journal of clinical nutrition, 91 5
Susa Sorkio, D. Cuthbertson, S. Bärlund, A. Reunanen, A. Nucci, C. Berseth, K. Koski, A. Ormisson, E. Savilahti, U. Uusitalo, J. Ludvigsson, D. Becker, J. Dupré, J. Krischer, M. Knip, H. Akerblom, S. Virtanen (2010)
Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trialDiabetes/Metabolism Research and Reviews, 26
J. Warram, A. Krolewski, Gottlieb Ms, C. Kahn (1984)
Differences in Risk of Insulin-Dependent Diabetes in Offspring of Diabetic Mothers and Diabetic FathersThe New England Journal of Medicine, 311
D. Dabelea, E. Mayer‐Davis, S. Saydah, G. Imperatore, B. Linder, J. Divers, R. Bell, Angela Badaru, Jennifer Talton, T. Crume, A. Liese, A. Merchant, J. Lawrence, K. Reynolds, L. Dolan, Lenna Liu, R. Hamman (2014)
Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.JAMA, 311 17
O Vaarala, J Ilonen, T Ruohtula (2012)
Removal of bovine insulin from cow?s milk formula and early initiation of beta-cell autoimmunity., 166
H. Åkerblom, The Group (2010)
The Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study: recruitment, intervention and follow-upDiabetologia, 54
P. Aranda, L. Sánchez, M. Pérez, J. Ena, Miguel Rebollar (1991)
Insulin in bovine colostrum and milk: evolution throughout lactation and binding to caseins.Journal of dairy science, 74 12
SM Virtanen, L Räsänen, A Aro (1991)
Infant feeding in Finnish children less than 7 yr of age with newly diagnosed IDDM., 14
Anna Parkkola, T. Härkönen, S. Ryhänen, J. Ilonen, M. Knip (2013)
Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed ChildrenDiabetes Care, 36
W. Karges, D. Hammond-Mckibben, R. Cheung, M. Visconti, N. Shibuya, Don Kemp, H. Dosch (1997)
Immunological Aspects of Nutritional Diabetes Prevention in NOD Mice: A Pilot Study for the Cow's Milk–Based IDDM Prevention TrialDiabetes, 46
ImportanceThe disease process leading to clinical type 1 diabetes often starts during the first years of life. Early exposure to complex dietary proteins may increase the risk of β-cell autoimmunity in children at genetic risk for type 1 diabetes. Extensively hydrolyzed formulas do not contain intact proteins. ObjectiveTo test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies in young children. Design, Setting, and ParticipantsA double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to January 2007 in 78 study centers in 15 countries; 1078 were randomized to be weaned to the extensively hydrolyzed casein formula and 1081 were randomized to be weaned to a conventional cows’ milk–based formula. The participants were observed to April 16, 2013. InterventionsThe participants received either a casein hydrolysate or a conventional cows’ milk formula supplemented with 20% of the casein hydrolysate. Main Outcomes and MeasuresPrimary outcome was positivity for at least 2 diabetes-associated autoantibodies out of 4 analyzed. Autoantibodies to insulin, glutamic acid decarboxylase, and the insulinoma-associated–2 (IA-2) molecule were analyzed using radiobinding assays and islet cell antibodies with immunofluorescence during a median observation period of 7.0 years (mean, 6.3 years). ResultsThe absolute risk of positivity for 2 or more islet autoantibodies was 13.4% among those randomized to the casein hydrolysate formula (n = 139) vs 11.4% among those randomized to the conventional formula (n = 117). The unadjusted hazard ratio for positivity for 2 or more autoantibodies among those randomized to be weaned to the casein hydrolysate was 1.21 (95% CI, 0.94-1.54), compared with those randomized to the conventional formula, while the hazard ratio adjusted for HLA risk, duration of breastfeeding, vitamin D use, study formula duration and consumption, and region was 1.23 (95% CI, 0.96-1.58). There were no clinically significant differences in the rate of reported adverse events between the 2 groups. Conclusions and RelevanceAmong infants at risk for type 1 diabetes, the use of a hydrolyzed formula, when compared with a conventional formula, did not reduce the incidence of diabetes-associated autoantibodies after 7 years. These findings do not support a benefit from hydrolyzed formula. Trial Registrationclinicaltrials.gov Identifier: NCT00179777
JAMA – American Medical Association
Published: Jun 11, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.